window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Biologics & Biosimilars,Biotech,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Abselion launches His-tag protein quantification kit and sensors for Amperia at PEGS Europe 2025

    Abselion has expanded its Amperia assay portfolio with the launch [...]

    November 11, 2025
  • Biotech,Clinical Development,Drug Development,Events and Conferences,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Medicinova wins contract research and development innovation award at biotech breakthrough awards 2025

    MediciNova has been recognised with the Contract Research and Development [...]

    November 10, 2025
  • Chronic diseases,Clinical Development,Clinical Trials,Drug Development,Pharmaceuticals and therapeutics,Research & Development

    nChroma Bio presents preclinical data showing epigenetic silencing approach as potential functional cure for chronic hepatitis B

    nChroma Bio has presented new preclinical data supporting its lead [...]

    November 7, 2025
  • Artificial Intelligence,Biomanufacturing,Digital Health,Drug Development,Technology and platforms

    The path to the autonomous lab: balancing innovation, culture, and compliance

    Laboratories across the pharmaceutical industry are moving closer to full [...]

    October 16, 2025
  • Artificial Intelligence,Clinical Development,Digital Health,Drug Development

    New AI tool offers real-time insights into clinical trial participant behavior

    Cognivia has launched Cognivia Signal, an AI-powered platform designed to [...]

    October 12, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Drug Development,Technology and platforms

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    October 12, 2025
  • Biologics & Biosimilars,Clinical Development,Clinical Trials,Drug Development,European biotech,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs

    Orexa announces positive interim data for Phase 2 trial in prevention of Post-Operative Ileus

    Orexa B.V., a Dutch life sciences company focused on improving [...]

    October 9, 2025
  • Biologics & Biosimilars,Clinical Development,Data Management,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    Thermo Fisher Scientific launches enterprise-ready Chromeleon 7.4 for chromatography and mass spectrometry

    Thermo Fisher Scientific has introduced Chromeleon 7.4 software, a fully [...]

    October 9, 2025
  • Central Nervous System,Drug Development,Pharmaceuticals and therapeutics,Rare Diseases

    FDA authorises Emalex Biosciences’ Expanded Access Program for Tourette syndrome drug

    Emalex Biosciences has received FDA authorisation for an Expanded Access [...]

    October 8, 2025
  • Central Nervous System,Clinical Trials,Drug Development,Pharmaceuticals and therapeutics

    Celon Pharma receives FDA clearance for Phase 3 trial of CPL’36 in schizophrenia

    Celon Pharma S.A. has received FDA clearance to advance its [...]

    October 8, 2025
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration
    Categories: Biomanufacturing, Cell & Gene Therapy, Drug Development, Manufacturing, Partnerships & Funding
  • Allucent adds strategy leaders to expand therapeutic expertise
    Categories: Clinical Development, Drug Development, Healthcare leadership, Movers & Shakers, Neurosciences, Oncology, Rare Diseases
  • Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform
    Categories: Biotech, Funding, Genetic Diseases, Mergers & Acquisitions, Research & Development, RNA Therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top